Skip to main content

dazodalibep

dazodalibep: 2 clinical trials tracked.

dazodalibep evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about dazodalibep, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

Clinical Trial Registry Records (2)

A Multicenter, Open-Label, Long-term, Extension Study to Evaluate the Safety and Tolerability of Dazodalibep in Participants With Sjögren's Syndrome (SS)

NCT06747949Registry updated 2026-04-28·Phase 3·AMGN
Recruiting

Primary endpoint: Number of Participants with Treatment-emergent Adverse Events (TEAEs)

Interventionalopen844 targetStarted 2025-02Completion 2029-1250 sites · Argentina, Australia, Belgium, Brazil…Amgen

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity

NCT06104124Registry updated 2026-09-14·Phase 3·AMGN
Completed

Primary endpoint: Change from baseline in European Alliance of Associations for Rheumatology Sjögren's Syndrome Disease Activity Index (ESSDAI) Score

InterventionalRandomizedquadruple651 enrolledStarted 2024-01Completion 2026-0850 sites · Argentina, United StatesAmgen